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Strengths and limitations of this study
 ► This study presents an explicit and replicable meth-
odology for analysing the effect of different types 
of physical exercise on health- related quality of life 
during and after cancer treatment, enhancing trans-
parency of research, reducing publication bias, pre-
venting selective publication and selective reporting 
of research outcomes.
 ► The publication of this protocol for a systematic 
review and network meta- analysis prevents unnec-
essary duplication of research, helping researchers 
to know which criteria for inclusion of trials are 
planned to be considered in the systematic review 
and network meta- analysis
 ► The assessment of risk of bias of the selected stud-
ies and heterogeneity among studies included, with 
particular reference to sample characteristics, is a 
featured point in this evidence review.
 ► Potential limitations of this research could be 
publication bias, information bias, poor statistical 
analysis and inadequate reporting of methods and 
findings within the included studies.
 ► This work will follow the existing guidelines includ-
ed in the Preferred Reporting Items for Systematic 
Review and Meta- Analysis and the Cochrane 
Collaboration Handbook, and it will take into account 
potential risks of bias for each study.
ABSTRACT
Introduction Cancer (and survival) is known to affect the 
quality of life. Strategies as physical activity and exercise 
during and after cancer may improve health- related qualify 
of life (HRQOL) outcomes and are, therefore, of clinical and 
public health importance. To the best of our knowledge, 
comparative evidence of the effect of the different types of 
exercise on improving HRQOL in cancer patients has not 
been synthesised thus far. We aim to conduct a systematic 
review and network meta- analysis in order to synthesise 
all available evidence regarding the effect of different 
types of exercise interventions on HRQOL during and after 
cancer treatment.
Methods and analysis MEDLINE (via PubMed), 
Web of Science, Embase, The Cochrane Library and 
SPORTDiscus will be searched from inception to 
December 2018 for relevant randomised controlled 
trials (RCTs) and non- RCTs. Studies assessing physical 
activity and exercise interventions in cancer patients 
(during treatment) and survivors (after treatment) will be 
selected. Two independent reviewers will identify eligible 
studies. After quality appraisal and data extraction, we 
will conduct meta- analyses for outcomes of interest, 
including data from mental and physical dimensions of 
cancer- specific and/or generic HRQOL questionnaires. 
Risk of bias assessments will be completed using the 
Quality Assessment Tool for Quantitative Studies. Study 
heterogeneity will be measured by the I2 statistic. Bayesian 
(and traditional approach) network meta- analysis will be 
performed when possible to determine the comparative 
effect of the different physical activity or exercise 
interventions.
Ethics and dissemination This systematic review and 
network meta- analysis will synthesise evidence on the 
effect of different types of exercise interventions on 
HRQOL during and after cancer treatment. The results will 
be disseminated by publication in a peer- reviewed journal 
and through scientific conferences and symposia. Ethical 
approval will not be required because the data used for 
this work will be exclusively extracted from published 
studies.
PROSPERO registration number CRD42019125028.
InTROduCTIOn
Cancer is a major cause of burden of disease 
worldwide and is responsible for one out of 
three deaths globally.1 2 However, as a conse-
quence of early diagnosis and timely treat-
ment strategies, survival rates are improving 
in such a way that cancer is now recognised as 
a chronic disease. Although improvements in 
the effectiveness of treatment options could 
improve survival,3 they also have a nega-
tive impact on physical and psychological 
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functions such as depression, anxiety, fatigue, pain, sleep 
quality and stress, all of which can affect the quality of life 
of cancer patients.4
Health- related qualify of life (HRQOL) is a multidi-
mensional construct reflecting patients’ perceptions 
regarding the effect of disease and its treatment on their 
physical, psychological and social functioning, and well- 
being.5 Importantly, growing evidence confirms that 
cancer survivors, especially younger patients, continue 
experiencing the detrimental effects of the disease not 
only during the early years after treatment, but also in 
the long term.6 Thus, since cancer must be considered 
a chronic disease with a negative impact on the physical, 
social and emotional life of cancer survivors,7 strategies to 
improve HRQOL outcomes during and after cancer are 
of clinical and public health importance.
Physical activity and exercise interventions are 
powerful tools associated with numerous benefits in 
terms of the HRQOL of cancer patients8–13 and survi-
vors,9 10 14 15 including improvement in cardiorespiratory 
and muscular fitness, reduction in fatigue and improve-
ment in body composition and well- being (ie, depres-
sion, anxiety, sleep quality and quality of life). As such, 
cancer patients and survivors have been encouraged to 
undertake regular exercise.16 17 However, the benefits that 
different types of exercise have on HRQOL are yet to be 
extensively studied.
There is a recent systematic review and network meta- 
analysis by Hilfiker et al18 that evaluated different types of 
exercise and/or other non- pharmaceutical interventions 
on cancer- related fatigue in any type of cancer during or 
after treatment. They found strong evidence that relax-
ation, yoga or cognitive–behavioural therapy, combined 
with physical activity or resistance or aerobic training, 
reduces cancer- related fatigue substantially more than 
usual care.18
To the best of our knowledge, comparative evidence of 
the effect of the different types of exercise on improving 
HRQOL in cancer patients has not been synthesised 
thus far. To achieve this, a network meta- analysis will be 
performed. Briefly, network meta- analysis is a relatively 
recent technique which extends the principles of meta- 
analysis to the evaluation of multiple treatments simul-
taneously in a single analysis by combining direct and 
indirect evidence. Therefore, we aim to conduct a system-
atic review and network meta- analysis in order to synthe-
sise all available evidence regarding the effect of different 
types of exercise interventions on HRQOL during and 
after cancer treatment.
METhOdS And AnAlySIS
This protocol has been registered within the PROSPERO 
database for systematic reviews and meta- analyses (regis-
tration number: CRD42019125028). The protocol has 
been designed and reported following the Preferred 
Reporting Items for Systematic Review and Meta- Analysis 
Protocols (PRISMA- P) statement19 and the Cochrane 
Collaboration Handbook.20
Inclusion/exclusion criteria for study selection
Type of studies
Because of the likely scarcity of studies, in addition to the 
barriers for randomisation of some interventions in cancer 
patients, the eligible studies will include randomised 
controlled trials, cluster randomised trials, cross- over 
trials, non- randomised experimental studies and two- 
arm prepost studies written in English or Spanish. For 
the cluster randomised trials, only the studies including 
the number of participants as unit of analysis will be 
included. For the cross- over trials, since the wash out 
period could represent an additional source of variability 
we will consider the outcomes of the first period. Only 
peer- reviewed publications will be included.
Type of participants
Studies assessing physical activity and exercise interven-
tions in cancer patients (during treatment) and survivors 
(after treatment) will be selected, regardless of the age of 
the participants or cancer site. Cancer patients (during 
treatment) will refer to those that received surgery and/
or undergone chemotherapy, radiotherapy or immuno-
therapy as an initial cancer treatment or as a treatment for 
metastasis or cancer recurrence. Cancer survivors (after 
treatment) will refer to those not receiving chemotherapy, 
radiotherapy or immunotherapy. Studies including both 
types of patients will be classified as mixed. When more 
than one study provides data from the same sample, we 
will only consider the one presenting the most detailed 
results or providing the longest follow- up data. However, 
data regarding sample characteristics could be extracted 
from multiple reports to obtain the most complete 
information.
Type of interventions
Eligible studies will report any type of physical exercise 
(aerobic, resistance, anaerobic, high- interval training, 
balance, stretching, alternatives (Pilates, yoga, Tai Chi) 
or a combination (eg, aerobic + resistance)). Physical 
exercise will be understood as repeated bouts over time 
involving more than one session/week with a duration 
of at least 4 weeks. However, studies combining phys-
ical activity and/or exercise with other health- related 
interventions, such as nutritional interventions, will 
be excluded when data cannot be separately extracted. 
Other intervention- related characteristics such as inten-
sity or supervision will be retrieved from each included 
study.
Type of outcome measurements
Overall HRQOL and specific HRQOL domains (eg, 
mental and physical domains) from cancer- specific and/
or generic HRQOL questionnaires will be selected for the 
meta- analysis. If the data are available and reliable scales 
were used, the studies will be combined in a meta- analysis.
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Table 1 Search strategy
cancer
OR tumour
OR tumor
OR oncology
OR chemotherapy
OR radiotherapy
AND exercise
OR
“physical activity”
OR aerobic
OR resistance
OR anaerobic
OR muscular
OR strength
OR cardiovascular
OR flexibility
OR balance
AND well- being
OR depression
OR anxiety
OR fatigue
OR
“sleep quality”
OR
“quality of life”
Figure 1 Preferred Reporting Items for Systematic Reviews 
and Meta- Analyses flow diagram of identification, screening, 
eligibility and inclusion of studies.
Search strategy
The literature search will be conducted in the following 
electronic databases from inception to December 2018: 
MEDLINE (via PubMed), Web of Science, Embase, The 
Cochrane Library, SPORTDiscus and CINAHL. Searches 
for unpublished studies will be conducted at OPEN 
GRAY, ProQuest dissertations & Thesis Global, Theseo, 
Networked digital library of theses and dissertations and 
Google Scholar. The search strategy will include the 
following text free terms (table 1): (cancer OR tumour 
OR tumor OR oncology OR chemotherapy OR radio-
therapy) AND (exercise OR “physical activity” OR aerobic 
OR resistance OR anaerobic OR muscular OR strength 
OR cardiovascular OR flexibility OR balance) AND (well- 
being OR depression OR anxiety OR fatigue OR pain 
OR stress OR “sleep quality” OR distress OR HRQOL 
OR QOL OR “physical functioning” OR “mental func-
tioning” OR “quality of life”). In addition, we will explore 
the reference lists of included articles and retrieve those 
studies that potentially meet the inclusion criteria.
There will be no limitations on the date of publication 
or on the location of the study. A librarian was consulted 
to draft the search strategy. The literature search will be 
independently conducted by two reviewers, and disagree-
ments will be solved by consensus or involving a third 
researcher.
Selection of studies and data extraction
Two independent reviewers will identify eligible studies by 
screen titles and abstracts, after removing duplicate works 
using Endnote software (Thomson Reuters). Reviewers 
will then examine the full texts and those that do not 
meet the selection criteria will be excluded, verifying the 
reasons for exclusion. Inconsistencies or disagreements 
will be solved by consensus or involving a third researcher. 
The process of identifying, screening and including or 
excluding studies will be shown using the PRISMA flow 
chart (figure 1).19
The following data will be extracted from the orig-
inal reports by the reviewers: (1) first author and year 
of publication, (2) country of the study where data were 
collected, (3) length of follow- up, (4) sample character-
istics (age, sample size, body mass index, stature, weight, 
type of population) (5) cancer characteristics (cancer 
type and stage of treatment), (6) intervention characteris-
tics (type of exercise, length, frequency) and (7) outcome 
measures (baseline and/or follow- up values).
Assessment of risk of bias
The methodological quality of the RCTs will be assessed 
using the Cochrane Collaboration’s tool for assessing risk 
of bias (RoB2).21 This tool includes five domains: (1) bias 
arising from the randomisation process, (2) bias due to 
deviations from intended interventions, (3) bias due to 
missing outcome data, (4) bias in measurement of the 
outcome and (5) bias in selection of the reported results 
(online supplementary file 1). To assess the risk of bias in 
non- RCTs, the Quality Assessment Tool for Quantitative 
Studies will be used.22 This tool evaluates seven domains: 
(1) selection bias, (2) study design, (3) confounders, (4) 
blinding, (5) data collection methods, (6) withdrawals 
and (7) dropouts. For both quality assessment tools, 
each domain will be assessed as ‘strong’, ‘moderate’ or 
‘weak’, and studies will be classified as low risk of bias 
(with no weak ratings), moderate risk of bias (with one 
weak rating) or high risk of bias (with two or more weak 
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ratings; online supplementary file 2). The agreement rate 
between reviewers will be reported by calculating kappa 
statistics. Any inconsistencies will be resolved by the third 
researcher.
Grading the quality of evidence
The Grading of Recommendations, Assessment, Devel-
opment and Evaluation tool will be used to assess the 
quality of the evidence and make recommendations.23 
Each outcome could obtain a high, moderate, low or 
very low evidence value, depending on the study design, 
risk of bias, inconsistency, indirect evidence, impreci-
sion and publication bias. By default, RCTs will receive 
an initial grade of high and will be downgraded based 
on the following prespecified criteria: risk of bias (weight 
of trials showing risk of bias by the RoB2 tool), inconsis-
tency (substantial unexplained inter- study heterogeneity, 
I2>50% and p<0.10), indirectness (presence of factors that 
limit the generalisability of the results), imprecision (the 
95% CIs for effect estimates are wide or cross a minimally 
important difference for benefit or harm) and publica-
tion bias (significant evidence of small- study effects).
Statistical analysis
The reviewers will design qualitative ad hoc tables to 
summarise the main characteristics of the selected 
studies (table 2), describing the types of direct and indi-
rect comparisons. The feasibility of doing a meta- analysis 
will be assessed after data extraction is completed. If a 
meta- analysis is not feasible, a narrative synthesis will be 
done. If a meta- analysis is possible, the random effects 
models based on the DerSimonian- Laird method will be 
used to perform a standard meta- analysis for each direct 
comparison between two interventions.24 Study hetero-
geneity will be measured by the I2 statistic and evaluated 
according to the following criteria: no relevant heteroge-
neity (0%–40%), moderate heterogeneity (30%–60%), 
substantial heterogeneity (50%–90%) and considerable 
heterogeneity (75%–100%).25 The corresponding p 
values will also be considered.
To compare the effect of the different types of physical 
activity or exercise interventions, a pairwise meta- analysis 
for direct and indirect comparisons between interventions 
and control/non- intervention will be carried out. Addi-
tionally, the effects of each intervention will be combined 
using Bayesian methods of the Markov- Monte Carlo chain 
using STATA V.15 software. The model developed by Dias 
et al26 for the UK National Institute for Health and Care 
Excellence Decision Support Unit will be used.
As the indirect comparisons are not protected by 
randomisation and maybe confounded by differences 
between the studies, we will check that all the participants 
in the studies included in the network meta- analysis have 
the same baseline characteristics (on average) that might 
modify the treatment effect.27
A graphic representation of the network will be used to 
assess the strength of the evidence, which will show the 
number of articles from which the information presented 
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comes from (treatment nodes), the comparisons that 
have direct comparisons and those that present indirect 
or mixed comparisons and the number of patients with 
different comparisons, in such a way that confidence in 
the results will be increased.28
The loop- specific approach will be used to evaluate 
the presence of inconsistency in network meta- analysis 
models locally.29 Difference (inconsistency factor) with 
95% CI between direct and indirect estimations for a 
specific comparison will be calculated to assess the pres-
ence of inconsistency in each loop. Inconsistency will 
be defined as disagreement between direct and indirect 
evidence with a 95% CI excluding 0.
To rank the physical activity and/or exercise inter-
ventions, the probability of each intervention being the 
most effective will be presented graphically by ranko-
grams. In addition, the surface under the cumulative 
ranking (SUCRA) will be calculated for each interven-
tion. SUCRA represents an inversely scaled average rank 
of the intervention, with a numerical value between 0 and 
1, the highest value meaning that the intervention always 
ranks first and the lowest value that it ranks last. The best 
intervention would obtain a value close to 1 and the worst 
intervention a value close to 0.30
Subgroup analyses
Subgroup analyses will be performed based on the type 
of participants, type of cancer, type of exercise performed 
and duration of the intervention, because these may be 
major factors causing heterogeneity.
Sensitivity analysis
Sensitivity analyses will be performed by excluding 
the included studies from the analysis one by one and 
comparing the results.
Patient and public involvement
Cancer patient organisations will be involved in both the 
discussion of the study results and the dissemination of 
the findings among stakeholders.
EThICS And dISSEMInATIOn
The resulting findings of this systematic review and 
network meta- analysis could help us develop high- quality 
recommendations about the type of physical activity and/
or exercise during and after cancer treatment in order to 
improve the HRQOL. Findings will be disseminated to 
academic audiences through peer- reviewed publications, 
as well as to clinical audiences, patients’ associations and 
policy- makers through conferences and symposia.
dISCuSSIOn
The health benefits of an active lifestyle during and after 
cancer treatment in the adult population have been 
described in the scientific literature. During cancer 
treatment, a systematic review of 14 RCTs in patients 
undergoing chemotherapy reported a positive effect of 
resistance and aerobic training in cardiorespiratory and 
muscular fitness.8 Likewise, a systematic review of 16 RCTs 
concluded that the practice of aerobic and/or resistance 
exercise during therapy (chemotherapy or radiotherapy) 
improved muscular strength.31 Another meta- analysis 
including 25 RCTs demonstrated the beneficial effects 
of aerobic, strength and flexibility exercises during treat-
ment in reducing the levels of cancer- related fatigue.9 
Similarly, two meta- analyses of 6 and 9 RCTs, respec-
tively, found that patients enrolled in aerobic exercise 
programme during cancer treatment had better sleep 
quality12 and depression outcomes,10 although the latter 
also included a strength training component.
Post- treatment exercise has also been associated with 
benefits to physical fitness, fatigue, mental health and 
well- being. Thus, cancer survivors practicing aerobic and 
resistance exercise improved cardiorespiratory (evidence 
from seven RCTs) and muscular (evidence from three 
RCTs) fitness.14 In addition, exercise programme 
including aerobic, strength and flexibility training have 
shown benefits towards levels of fatigue (15 RCTs),9 
quality of life (11 RCTs),15 anxiety (4 RCTs)15 and depres-
sion (9 RCTs).10 Finally, evidence from a meta- analysis 
showed improvements in body weight (16 RCTs) and 
body fat (10 RCTs) following aerobic and resistance exer-
cise programme.14
In our opinion, the scientific literature lacks a meta- 
synthesis of evidence comparing the benefits of different 
exercise interventions on HRQOL during and after 
cancer treatment. A recent systematic review that included 
a network meta- analysis assessed the effects of different 
types of exercise and other non- pharmaceutical interven-
tions on cancer- related fatigue during and after cancer 
treatment.18 Although cancer- related fatigue is one of 
the most common and distressing symptoms of cancer,18 
it is only one of the many components that define the 
multidimensional concept of HRQOL.5 Recent works 
from Buffart et al32 and Sweegers et al4 evaluated the 
effect of exercise on quality of life and physical function 
in cancer patients. Our systematic review and network 
meta- analysis will synthesise all the available evidence on 
the effects that different types of exercise have on the 
different domains (including both physical and mental 
domains) of HRQOL during and after cancer treatment, 
using, apart from the traditional meta- analysis method-
ology, a comprehensive network meta- analysis approach 
that allow us to provide both direct and indirect inter-
vention’s comparisons.
Potential limitations of this research could be publica-
tion bias, information bias, poor statistical analysis and 
inadequate reporting of methods and findings within 
the included studies.33 In addition, it is likely that we 
find studies in which the treatment lasted longer than 
the exercise interventions performed, and therefore, we 
might not be able to firmly conclude about the optimal 
exercise dose/duration. This work will follow the existing 
guidelines included in the PRISMA19 and the Cochrane 
Collaboration Handbook.20 In addition, it will take into 
account potential risks of bias for each study.
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Given the importance of health outcomes in terms of 
a good quality of life in cancer patients and survivors, a 
more detailed and comprehensive review on the effects of 
different types of exercise on health parameters in cancer 
survivors is necessary. This protocol provides a clear and 
structured procedure for maximising the extraction of 
relevant information, and provides summarised informa-
tion. The findings of this systematic review and network 
meta- analysis could be of interest to patients, practi-
tioners, researchers and policy- makers since they will 
provide evidence that will assist in the development of 
effective exercise and/or physical activity programme in 
these populations.
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